🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

100 mg Serving Size
200 Servings
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

500 mg
📊 Market median: 500.0mg (9 products)
This product: 500mg

Other Ingredients

None

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (92% of products) Nutrient (35% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 100 mg (about 1/16 tsp) to 500 mg (rounded 1/4 tsp) daily, or as directed by a physician.

⚠️ Warnings & Precautions

Warning: This product is not intended for use by those with a serious medical condition or pregnant or lactating women.

Consult your physician before use.

Keep out of reach of children!

🧪 Formulation Notes

(PABA)

Free of: sugar, soy, dairy, yeast, gluten or additives.

Additional Information

Clean & Pure Bulk Supplements

US Standard Measuring Spoons Spoon Size (level) milligrams 1/16 teaspoon 109 1/8 teaspoon 219 1/4 teaspoon 438

Storage: keep dry, cool & dark.

Product Details

DSLD Entry Date 2021-07-27
Product Type Non-Nutrient/Non-Botanical
Form Powder
DSLD ID 252646
Data Updated 2026-04-11

Research Evidence

7 Research Sources
26 Avg Quality Score
5 Other
2 Rct
C Para-aminobenzoic acid (PABA) used as a marker for completeness of 24 hour urine: effects of age and dosage scheduling
Rct European journal of clinical nutrition 2003
D [The diagnostic value of serum PABA determination in pancreatic disease and in relation to anticholinergic medication]
Rct Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR 1989
D Para-aminobenzoic acid therapy in scleroderma and lymphoblastoma cutis
Other The Journal of laboratory and clinical medicine 1948
F The PABA story
Other The Australasian journal of dermatology 1999
F Sodium para-aminobenzoate PABA in the treatment of dermatoses
Other The Journal of investigative dermatology 1952
F Para-aminobenzoic acid therapy in lymphoblastoma cutis and mycosis fungoides
Other Cancer 1954
F Photochemical formation of singlet molecular oxygen (1O2) in illuminated aqueous solutions of p-aminobenzoic acid (PABA)
Other Journal of photochemistry and photobiology. B, Biology 1996
View all evidence for Paba →

Compare Similar Products

View all Paba products →